| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 10/01/2009 | US20090247526 Glucokinase activators |
| 10/01/2009 | US20090247525 Sigma receptor inhibitors |
| 10/01/2009 | US20090247517 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 10/01/2009 | US20090247515 11 Beta-HSD1 Modulators |
| 10/01/2009 | US20090247496 Pharmaceutical composition and extract of poria for enhancing uptake of nutrients |
| 10/01/2009 | US20090247489 Dihydroxyl compounds and compositions for cholesterol management and related uses |
| 10/01/2009 | US20090247467 Peptide epitopes of vegfr-2/kdr that inhibit angiogenesis |
| 10/01/2009 | US20090247463 Polymer-based sustained release device |
| 10/01/2009 | US20090247456 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 10/01/2009 | US20090247454 Method for detecting a predisposition to develop gestational diabetes mellitus and treatment for this disease |
| 10/01/2009 | US20090246303 Method for Reducing The Effects of Chemotherapy Using Flagellin Related Polypeptides |
| 10/01/2009 | US20090246290 Lipid metabolism improving agent containing hydrogen molecules |
| 10/01/2009 | US20090246267 Carnitine Conjugates of Adamantanamines and Neramexane Derivatives as Dual Prodrugs for Various Uses |
| 10/01/2009 | US20090246232 Pharmaceutical composition |
| 10/01/2009 | US20090246201 Substances |
| 10/01/2009 | US20090246183 eNOS mutations useful for gene therapy and therapeutic screening |
| 10/01/2009 | US20090246178 Cd56 positive human adult pancreatic endocrine progenitor cells |
| 10/01/2009 | US20090246177 Megasphaera elsdenii strain and its uses |
| 10/01/2009 | US20090246176 Method for treating diabetes mellitus, obesity, chronic fatigue, aging, and other medical conditions by utilizing modified virus virions to insert messenger ribonucleic acid molecules into cells |
| 10/01/2009 | CA2719247A1 Ikki inhibitor therapies and screening methods, and related ikki diagnostics |
| 10/01/2009 | CA2718983A1 Heterocyclic compounds as adenosine receptor antagonist |
| 10/01/2009 | CA2717384A1 Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism |
| 10/01/2009 | CA2716961A1 Azetidine-derived compounds, preparation method therefor and therapeutic use of same |
| 09/30/2009 | EP2105449A2 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 09/30/2009 | EP2105442A1 Method for producing c-glycoside derivative and synthetic intermediate thereof |
| 09/30/2009 | EP2105136A2 Pharmaceutical compositions for treating cancer |
| 09/30/2009 | EP2105135A2 Pharmaceutical compositions for treating cancer |
| 09/30/2009 | EP2104673A2 New 2, 4-dianilinopyrimidines, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors |
| 09/30/2009 | EP2104533A2 Use of substances reducing cellular glutathione content for producing a medicament for treating t-cell mediated autoimmune diseases |
| 09/30/2009 | EP1553089B1 Antagonist of melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient |
| 09/30/2009 | EP1242122B1 Delivery of proteins across polar epithelial cell layers |
| 09/30/2009 | CN101544981A Method for preparing bitter melon polypeptide with function of reducing blood sugar bioactivity by gene engineering and application |
| 09/30/2009 | CN101544578A Preparing method for phenyl acetic acid derivates and applications in medicament |
| 09/30/2009 | CN101544575A Method for preparing natural 4-hydroxy-isoleucine |
| 09/30/2009 | CN101543628A Medicament and preparation thereof for treating hyperlipemia and atherosclerosis |
| 09/30/2009 | CN101543621A Drug for curing diabetes |
| 09/30/2009 | CN101543591A Medical composition for treating diabetes and preparation method thereof |
| 09/30/2009 | CN101543579A Medicine for treating diabetes |
| 09/30/2009 | CN101543569A Donkey-hide glue nourishing ointment and preparing method thereof |
| 09/30/2009 | CN101543568A Yam total sapogenin sustained-release pellet as well as preparation method and application thereof |
| 09/30/2009 | CN101543554A Anaesthetic for curing hyperlipoidemia |
| 09/30/2009 | CN101543549A Chinese lizardtail flavone dripping pill |
| 09/30/2009 | CN101543548A Chinese lizardtail flavone quick release preparation |
| 09/30/2009 | CN101543546A Antioxidative substance and composition and use thereof |
| 09/30/2009 | CN101543532A Traditional Chinese medicine for treating coronary disease, angina pectoris and apoplexy sequelae and preparation method thereof |
| 09/30/2009 | CN101543526A Kudzu root total aglycone sustained-release pellet as well as preparation method and application thereof |
| 09/30/2009 | CN101543517A Folium ginkgo total flavonoid aglycone sustained-release pellet as well as preparation method and application thereof |
| 09/30/2009 | CN101543512A Method for producing dry earthworm powder |
| 09/30/2009 | CN101543500A Dhea composition and method |
| 09/30/2009 | CN101543489A Compounds as liver X receptor modifier |
| 09/30/2009 | CN101543476A A naringin solid dispersion and the preparation method, and the application thereof |
| 09/30/2009 | CN101543298A Rutin chewing agent and method for preparing same |
| 09/30/2009 | CN100544726C DHEA composition and method |
| 09/30/2009 | CN100544715C Composition of free-B-ring flavonoids and flavans as a therapeutic agent |
| 09/29/2009 | US7596455 Crystallization of IGF-1 |
| 09/29/2009 | US7595403 Such as 3-Oxo-3H-benzo[d]isothiazole-2-carboxylic acid allylamide for treating hypercholesterolemia, hyperlipidemia, or atherosclerosis |
| 09/29/2009 | US7595399 Tyrosine derivatives |
| 09/29/2009 | US7595329 4-{[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}tetrahydro-2H-pyran-4-carboxylic acid; serotonin receptor agonist; gastroesophageal reflux disease, analgesic, cognition activator; less toxicity, good absorption, and metabolic stability |
| 09/29/2009 | US7595321 Useful for the prevention and/or treatment of cognitive disorders; 3-Amino-N-(2-cyanoethyl)-6-[4-(pyrrolidin-1-ylsulfonyl)phenyl]pyrazine-2-carboxamide, for example |
| 09/29/2009 | US7595319 Compounds having selective inhibiting effect at GSK3 |
| 09/29/2009 | US7595316 2-(1-Cyclopentylpiperidin-4-yloxy)-5-(4-cyanophenyl)pyrimidine, for example; exhibits histamine receptor H3 antagonist or inverse agonist activity and is useful for the treatment and/or prevention of obesity, diabetes, hormonal secretion abnormality, sleep disorders |
| 09/29/2009 | US7595311 Azepinoindole derivatives as pharmaceutical agents |
| 09/29/2009 | CA2494601C N-substituted-1h-indol-5-propionic acid compounds as ppar agonists useful for the treatment of diabetes |
| 09/29/2009 | CA2481263C Use of pyrimidine nucleotides for the treatment of affections of the peripheral nervous system |
| 09/29/2009 | CA2469882C Novel stable crystals of substituted phenylpropionic acid derivative and process for producing the same |
| 09/29/2009 | CA2469350C 3-{4-methyl-3[methyl-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile mono citrate salt |
| 09/29/2009 | CA2457944C Polycyclic guanine phosphodiesterase v inhibitors |
| 09/29/2009 | CA2394079C Weight promoting composition, method and product |
| 09/29/2009 | CA2383983C Substituted indolealkanoic acids |
| 09/29/2009 | CA2318208C Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/29/2009 | CA2313372C Composition and method for prolonging the useful life of enteral feeding tubes |
| 09/29/2009 | CA2259148C Solid oral dosage forms of valsartan |
| 09/29/2009 | CA2255171C 1,3,8-triaza-spiro[4,5]decan-4-on derivatives |
| 09/29/2009 | CA2176796C Substituted benzyloxycarbonylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 09/24/2009 | WO2009117676A2 Novel piperidine derivatives as inhibitors of stearoyl-coa desaturase |
| 09/24/2009 | WO2009117669A2 Treatment with opioid antagonists and mtor inhibitors |
| 09/24/2009 | WO2009116695A1 A composition for treatment and improvement of diabetes comprising caveolin as active ingredient and a method for treatment of diabetes using it |
| 09/24/2009 | WO2009116636A1 Mineral-enriched soybean protein solution |
| 09/24/2009 | WO2009116557A1 Drug-containing composition |
| 09/24/2009 | WO2009116382A1 Inhibitor for blood phosphorus level elevation |
| 09/24/2009 | WO2009115558A1 Fungicide hydroximoyl-tetrazole derivatives |
| 09/24/2009 | WO2009115486A1 Triazole amide derivatives for use in therapy |
| 09/24/2009 | WO2009115023A1 A anthocyanins phospholipid complex and the preparative method thereof |
| 09/24/2009 | WO2009087285A4 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof |
| 09/24/2009 | WO2009082152A3 Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient |
| 09/24/2009 | WO2009076454A3 Compounds that modulate intracellular calcium |
| 09/24/2009 | WO2009070314A3 Crystalline form of sitagliptin |
| 09/24/2009 | WO2009059755A3 Novel neurturin conjugates for pharmaceutical use |
| 09/24/2009 | WO2009040068A3 Use of a peptide as a therapeutic agent |
| 09/24/2009 | WO2009040067A3 Use of a peptide as a therapeutic agent |
| 09/24/2009 | WO2009040049A3 Use of acetyl- (ala10, 11)-rantes (1-14) and/or calcitonin as anti-angiogenic agents |
| 09/24/2009 | WO2009033681A3 Cyclo-argd as a therapeutic agent |
| 09/24/2009 | WO2009033680A3 Galanin-like peptide alone or in combination with cyclo-argd as a therapeutic agent |
| 09/24/2009 | WO2009004076A3 Supplemention of maternal diet |
| 09/24/2009 | US20090239917 Heterocyclic Cycloalkyl Compounds, a Process for their Preparation and Pharmaceutical Compositions Containing Them |
| 09/24/2009 | US20090239911 Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 09/24/2009 | US20090239909 Treatment of metabolic syndrome with lactams |
| 09/24/2009 | US20090239877 Novel 1,2,4-triazole derivatives and process of manufacturing thereof |
| 09/24/2009 | US20090239864 6- (pyridinyl) -4-pyrimidone derivates as tau protein kinase 1 inhibitors |
| 09/24/2009 | US20090239862 Substituted Imidazole 4-Carboxamides as Cholecystokinin-1 Receptor Modulators |